Literature DB >> 2718784

Bone mineral density in women with type II diabetes mellitus.

R S Weinstock1, R S Goland, E Shane, T L Clemens, R Lindsay, J P Bilezikian.   

Abstract

Bone mineral density (BMD) was assessed in 28 women with type II diabetes mellitus and compared to 207 age-matched nondiabetic women. Mean BMD, as measured by dual-photon absorptiometry, 1.12 +/- 0.3 g/cm2 (+/- SEM), was similar to the mean BMD of control subjects, 1.06 +/- 0.1 g/cm2. Only 1 of the 28 diabetic patients had a BMD less than 0.95 g/cm2 ("fracture threshold"), whereas 25% of the control subjects had a BMD below that level. When diabetic and control subjects were matched for weight as well as age, the data continued to show similar BMD among both groups. Moreover, the disparity between the proportion of weight-matched controls (25%) and diabetic subjects (1 of 28) with a BMD below the fracture threshold persisted. Among the group of 17 diabetic subjects receiving insulin, there was a positive relationship between BMD and insulin dose. There was no significant relationship between BMD, duration of diabetes, or hemoglobin Alc. Thus, women with type II diabetes are not at increased risk for diminished BMD and may be protected against bone loss.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2718784     DOI: 10.1002/jbmr.5650040114

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  20 in total

Review 1.  Osteoporosis and diabetes mellitus.

Authors:  Angela M Inzerillo; Solomon Epstein
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

2.  Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.

Authors:  T Shibata; S Takeuchi; S Yokota; K Kakimoto; F Yonemori; K Wakitani
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

Review 3.  Diabetes pharmacotherapy and effects on the musculoskeletal system.

Authors:  Evangelia Kalaitzoglou; John L Fowlkes; Iuliana Popescu; Kathryn M Thrailkill
Journal:  Diabetes Metab Res Rev       Date:  2018-12-20       Impact factor: 4.876

Review 4.  Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis.

Authors:  P Vestergaard
Journal:  Osteoporos Int       Date:  2006-10-27       Impact factor: 4.507

Review 5.  Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues.

Authors:  Kathryn M Thrailkill; Charles K Lumpkin; R Clay Bunn; Stephen F Kemp; John L Fowlkes
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-11       Impact factor: 4.310

6.  Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk.

Authors:  P Vestergaard; L Rejnmark; L Mosekilde
Journal:  Diabetologia       Date:  2005-05-21       Impact factor: 10.122

7.  Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study.

Authors:  I I de Liefde; M van der Klift; C E D H de Laet; P L A van Daele; A Hofman; H A P Pols
Journal:  Osteoporos Int       Date:  2005-06-07       Impact factor: 4.507

Review 8.  Diabetes and fractures: an overshadowed association.

Authors:  Natasha B Khazai; George R Beck; Guillermo E Umpierrez
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-12       Impact factor: 3.243

9.  Contributions of the Insulin/Insulin-Like Growth Factor-1 Axis to Diabetic Osteopathy.

Authors:  John L Fowlkes; Clay Bunn R; Kathryn M Thrailkill
Journal:  J Diabetes Metab       Date:  2011-11-25

10.  Bone mineral density in the femur and lumbar vertebrae decreases after twelve weeks of diabetes in spontaneously diabetic-prone BB/Worcester rats.

Authors:  C E Waud; S C Marks; R Lew; D T Baran
Journal:  Calcif Tissue Int       Date:  1994-03       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.